Starting from an early embryonic stage, maternal gut microbiota-SCFA-FFAR2 signaling plays a crucial role in regulating metabolic syndrome, as FFAR2 KO mice embryos have lower insulin and higher glucose level, and are more susceptible to obesity and diabetes in adulthood [209]. The gene discussed is FFAR2; the disease is metabolic syndrome.